Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Plos One
|
June 24, 2021
A hidden web of policy influence: The pharmaceutical industry's engagement with UK's All-Party Parliamentary Groups
Emily Rickard, Piotr Ozieranski
Sociology of Health & Illness
|
July 15, 2021
Divergent spender: State-societal and meso-organisational mechanisms in the containment of public spending on pharmaceuticals in a liberal capitalist democracy
Ben Main, Piotr Ozieranski
BMJ Open
|
October 23, 2018
Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts
Shai Mulinari, Piotr Ozieranski
Plos One
|
December 7, 2021
Drug company payments to General Practices in England: Cross-sectional and social network analysis
Eszter Saghy, Shai Mulinari, Piotr Ozieranski
Health Policy (Amsterdam, Netherlands)
|
August 29, 2019
Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK
Emily Rickard, Piotr Ozieranski, Shai Mulinari
Health Policy (Amsterdam, Netherlands)
|
November 12, 2022
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
Shai Mulinari, Dylan Pashley, Piotr Ozieranski
BMJ Open
|
March 29, 2023
Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
Emily Rickard, Emma Carmel, Piotr Ozieranski
Plos One
|
November 1, 2023
Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
Piotr Ozieranski, Eszter Saghy, Shai Mulinari
International Journal of Social Determinants of Health and Health Services
|
December 27, 2024
Pharmaceutical Industry Payments to Patient Organizations in Poland: Analysis of the Patterns, Evolution, and Structure of Connections
Marta Makowska, Shai Mulinari, Piotr Ozieranski
International Journal of Health Services : Planning, Administration, Evaluation
|
March 1, 2022
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
Dylan Pashley, Piotr Ozieranski, Shai Mulinari
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Plos One
|
June 24, 2021
A hidden web of policy influence: The pharmaceutical industry's engagement with UK's All-Party Parliamentary Groups
Emily Rickard, Piotr Ozieranski
Sociology of Health & Illness
|
July 15, 2021
Divergent spender: State-societal and meso-organisational mechanisms in the containment of public spending on pharmaceuticals in a liberal capitalist democracy
Ben Main, Piotr Ozieranski
BMJ Open
|
October 23, 2018
Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts
Shai Mulinari, Piotr Ozieranski
Plos One
|
December 7, 2021
Drug company payments to General Practices in England: Cross-sectional and social network analysis
Eszter Saghy, Shai Mulinari, Piotr Ozieranski
Health Policy (Amsterdam, Netherlands)
|
August 29, 2019
Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK
Emily Rickard, Piotr Ozieranski, Shai Mulinari
Health Policy (Amsterdam, Netherlands)
|
November 12, 2022
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
Shai Mulinari, Dylan Pashley, Piotr Ozieranski
BMJ Open
|
March 29, 2023
Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
Emily Rickard, Emma Carmel, Piotr Ozieranski
Plos One
|
November 1, 2023
Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
Piotr Ozieranski, Eszter Saghy, Shai Mulinari
International Journal of Social Determinants of Health and Health Services
|
December 27, 2024
Pharmaceutical Industry Payments to Patient Organizations in Poland: Analysis of the Patterns, Evolution, and Structure of Connections
Marta Makowska, Shai Mulinari, Piotr Ozieranski
International Journal of Health Services : Planning, Administration, Evaluation
|
March 1, 2022
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
Dylan Pashley, Piotr Ozieranski, Shai Mulinari
Page
of 4